-
1
-
-
0023144684
-
Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines
-
Baker C.C., Phelps W.C., Lindgren V., Braun M.J., Gonda M.A., Howley P.M. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J. Virol. 1987, 61:962-971.
-
(1987)
J. Virol.
, vol.61
, pp. 962-971
-
-
Baker, C.C.1
Phelps, W.C.2
Lindgren, V.3
Braun, M.J.4
Gonda, M.A.5
Howley, P.M.6
-
2
-
-
0347634431
-
Nuclear localization but not PML protein is required for incorporation of the papillomavirus minor capsid protein L2 into virus-like particles
-
Becker K.A., Florin L., Sapp C., Maul G.G., Sapp M. Nuclear localization but not PML protein is required for incorporation of the papillomavirus minor capsid protein L2 into virus-like particles. J. Virol. 2004, 78:1121-1128.
-
(2004)
J. Virol.
, vol.78
, pp. 1121-1128
-
-
Becker, K.A.1
Florin, L.2
Sapp, C.3
Maul, G.G.4
Sapp, M.5
-
3
-
-
0141680274
-
Dissection of human papillomavirus type 33 L2 domains involved in nuclear domains (ND) 10 homing and reorganization
-
Becker K.A., Florin L., Sapp C., Sapp M. Dissection of human papillomavirus type 33 L2 domains involved in nuclear domains (ND) 10 homing and reorganization. Virology 2003, 314:161-167.
-
(2003)
Virology
, vol.314
, pp. 161-167
-
-
Becker, K.A.1
Florin, L.2
Sapp, C.3
Sapp, M.4
-
4
-
-
0029934487
-
Conserved features in papillomavirus and polyomavirus capsids
-
Belnap D.M., Olson N.H., Cladel N.M., Newcomb W.W., Brown J.C., Kreider J.W., Christensen N.D., Baker T.S. Conserved features in papillomavirus and polyomavirus capsids. J. Mol. Biol. 1996, 259:249-263.
-
(1996)
J. Mol. Biol.
, vol.259
, pp. 249-263
-
-
Belnap, D.M.1
Olson, N.H.2
Cladel, N.M.3
Newcomb, W.W.4
Brown, J.C.5
Kreider, J.W.6
Christensen, N.D.7
Baker, T.S.8
-
5
-
-
84871940100
-
SNX17 facilitates infection with diverse papillomavirus types
-
Bergant M., Banks L. SNX17 facilitates infection with diverse papillomavirus types. J. Virol. 2013, 87:1270-1273.
-
(2013)
J. Virol.
, vol.87
, pp. 1270-1273
-
-
Bergant, M.1
Banks, L.2
-
6
-
-
84856808484
-
Human papillomavirus L2 facilitates viral escape from late endosomes via sorting nexin 17
-
Bergant Marusic M., Ozbun M.A., Campos S.K., Myers M.P., Banks L. Human papillomavirus L2 facilitates viral escape from late endosomes via sorting nexin 17. Traffic 2012, 13:455-467.
-
(2012)
Traffic
, vol.13
, pp. 455-467
-
-
Bergant Marusic, M.1
Ozbun, M.A.2
Campos, S.K.3
Myers, M.P.4
Banks, L.5
-
7
-
-
77950938389
-
Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments
-
Bernard H.U., Burk R.D., Chen Z., van Doorslaer K., Hausen H., de Villiers E.M. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 2010, 401:70-79.
-
(2010)
Virology
, vol.401
, pp. 70-79
-
-
Bernard, H.U.1
Burk, R.D.2
Chen, Z.3
van Doorslaer, K.4
Hausen, H.5
de Villiers, E.M.6
-
8
-
-
70049114748
-
Target cell cyclophilins facilitate human papillomavirus type 16 infection
-
Bienkowska-Haba M., Patel H.D., Sapp M. Target cell cyclophilins facilitate human papillomavirus type 16 infection. PLoS Pathog. 2009, 5:e1000524.
-
(2009)
PLoS Pathog.
, vol.5
-
-
Bienkowska-Haba, M.1
Patel, H.D.2
Sapp, M.3
-
9
-
-
84866170686
-
Cyclophilins facilitate dissociation of the human papillomavirus type 16 capsid protein L1 from the L2/DNA complex following virus entry
-
Bienkowska-Haba M., Williams C., Kim S.M., Garcea R.L., Sapp M. Cyclophilins facilitate dissociation of the human papillomavirus type 16 capsid protein L1 from the L2/DNA complex following virus entry. J. Virol. 2012, 86:9875-9887.
-
(2012)
J. Virol.
, vol.86
, pp. 9875-9887
-
-
Bienkowska-Haba, M.1
Williams, C.2
Kim, S.M.3
Garcea, R.L.4
Sapp, M.5
-
10
-
-
33746820185
-
The l2 minor capsid protein of low-risk human papillomavirus type 11 interacts with host nuclear import receptors and viral DNA
-
Bordeaux J., Forte S., Harding E., Darshan M.S., Klucevsek K., Moroianu J. The l2 minor capsid protein of low-risk human papillomavirus type 11 interacts with host nuclear import receptors and viral DNA. J. Virol. 2006, 80:8259-8262.
-
(2006)
J. Virol.
, vol.80
, pp. 8259-8262
-
-
Bordeaux, J.1
Forte, S.2
Harding, E.3
Darshan, M.S.4
Klucevsek, K.5
Moroianu, J.6
-
11
-
-
18744365783
-
Interaction of tSNARE syntaxin 18 with the papillomavirus minor capsid protein mediates infection
-
Bossis I., Roden R.B., Gambhira R., Yang R., Tagaya M., Howley P.M., Meneses P.I. Interaction of tSNARE syntaxin 18 with the papillomavirus minor capsid protein mediates infection. J. Virol. 2005, 79:6723-6731.
-
(2005)
J. Virol.
, vol.79
, pp. 6723-6731
-
-
Bossis, I.1
Roden, R.B.2
Gambhira, R.3
Yang, R.4
Tagaya, M.5
Howley, P.M.6
Meneses, P.I.7
-
12
-
-
18144398862
-
Human papillomavirus 16 virus-like particles use heparan sulfates to bind dendritic cells and colocalize with langerin in Langerhans cells
-
Bousarghin L., Hubert P., Franzen E., Jacobs N., Boniver J., Delvenne P. Human papillomavirus 16 virus-like particles use heparan sulfates to bind dendritic cells and colocalize with langerin in Langerhans cells. J. Gen. Virol. 2005, 86:1297-1305.
-
(2005)
J. Gen. Virol.
, vol.86
, pp. 1297-1305
-
-
Bousarghin, L.1
Hubert, P.2
Franzen, E.3
Jacobs, N.4
Boniver, J.5
Delvenne, P.6
-
13
-
-
0029025444
-
Immunization with virus-like particles from cottontail rabbit papillomavirus (Crpv) can protect against experimental Crpv infection
-
Breitburd F., Kirnbauer R., Hubbert N.L., Nonnenmacher B., Trindinhdesmarquet C., Orth G., Schiller J.T., Lowy D.R. Immunization with virus-like particles from cottontail rabbit papillomavirus (Crpv) can protect against experimental Crpv infection. J. Virol. 1995, 69:3959-3963.
-
(1995)
J. Virol.
, vol.69
, pp. 3959-3963
-
-
Breitburd, F.1
Kirnbauer, R.2
Hubbert, N.L.3
Nonnenmacher, B.4
Trindinhdesmarquet, C.5
Orth, G.6
Schiller, J.T.7
Lowy, D.R.8
-
14
-
-
84871986425
-
A transmembrane domain and GxxxG motifs within L2 are essential for papillomavirus infection
-
Bronnimann M.P., Chapman J.A., Park C.K., Campos S.K. A transmembrane domain and GxxxG motifs within L2 are essential for papillomavirus infection. J. Virol. 2013, 87:464-473.
-
(2013)
J. Virol.
, vol.87
, pp. 464-473
-
-
Bronnimann, M.P.1
Chapman, J.A.2
Park, C.K.3
Campos, S.K.4
-
15
-
-
43949123577
-
Arrangement of L2 within the papillomavirus capsid
-
Buck C.B., Cheng N., Thompson C.D., Lowy D.R., Steven A.C., Schiller J.T., Trus B.L. Arrangement of L2 within the papillomavirus capsid. J. Virol. 2008, 82:5190-5197.
-
(2008)
J. Virol.
, vol.82
, pp. 5190-5197
-
-
Buck, C.B.1
Cheng, N.2
Thompson, C.D.3
Lowy, D.R.4
Steven, A.C.5
Schiller, J.T.6
Trus, B.L.7
-
16
-
-
0346688642
-
Efficient intracellular assembly of papillomaviral vectors
-
Buck C.B., Pastrana D.V., Lowy D.R., Schiller J.T. Efficient intracellular assembly of papillomaviral vectors. J. Virol. 2004, 78:751-757.
-
(2004)
J. Virol.
, vol.78
, pp. 751-757
-
-
Buck, C.B.1
Pastrana, D.V.2
Lowy, D.R.3
Schiller, J.T.4
-
17
-
-
84858271333
-
The papillomavirus virion: a machine built to hide molecular Achilles' heels
-
Buck C.B., Trus B.L. The papillomavirus virion: a machine built to hide molecular Achilles' heels. Adv. Exp. Med. Biol. 2012, 726:403-422.
-
(2012)
Adv. Exp. Med. Biol.
, vol.726
, pp. 403-422
-
-
Buck, C.B.1
Trus, B.L.2
-
18
-
-
0030790229
-
A peptide encoding a B-cell epitope from the N-terminus of the capsid protein L2 of bovine papillomavirus-4 prevents disease
-
Campo M.S., O'Neil B.W., Grindlay G.J., Curtis F., Knowles G., Chandrachud L. A peptide encoding a B-cell epitope from the N-terminus of the capsid protein L2 of bovine papillomavirus-4 prevents disease. Virology 1997, 234:261-266.
-
(1997)
Virology
, vol.234
, pp. 261-266
-
-
Campo, M.S.1
O'Neil, B.W.2
Grindlay, G.J.3
Curtis, F.4
Knowles, G.5
Chandrachud, L.6
-
19
-
-
84887212439
-
Two highly conserved cysteine residues in HPV16 L2 form an intramolecular disulfide bond and are critical for infectivity in human keratinocytes
-
Campos S.K., Ozbun M.A. Two highly conserved cysteine residues in HPV16 L2 form an intramolecular disulfide bond and are critical for infectivity in human keratinocytes. PloS One 2009, 4:e4463.
-
(2009)
PloS One
, vol.4
-
-
Campos, S.K.1
Ozbun, M.A.2
-
20
-
-
0025755278
-
The open reading frame L2 of cottontail rabbit papillomavirus contains antibody-inducing neutralizing epitopes
-
Christensen N.D., Kreider J.W., Kan N.C., DiAngelo S.L. The open reading frame L2 of cottontail rabbit papillomavirus contains antibody-inducing neutralizing epitopes. Virology 1991, 181:572-579.
-
(1991)
Virology
, vol.181
, pp. 572-579
-
-
Christensen, N.D.1
Kreider, J.W.2
Kan, N.C.3
DiAngelo, S.L.4
-
21
-
-
70349840682
-
Overlapping and independent structural roles for human papillomavirus type 16 L2 conserved cysteines
-
Conway M.J., Alam S., Christensen N.D., Meyers C. Overlapping and independent structural roles for human papillomavirus type 16 L2 conserved cysteines. Virology 2009, 393:295-303.
-
(2009)
Virology
, vol.393
, pp. 295-303
-
-
Conway, M.J.1
Alam, S.2
Christensen, N.D.3
Meyers, C.4
-
22
-
-
70349750271
-
Tissue-spanning redox gradient-dependent assembly of native human papillomavirus type 16 virions
-
Conway M.J., Alam S., Ryndock E.J., Cruz L., Christensen N.D., Roden R.B., Meyers C. Tissue-spanning redox gradient-dependent assembly of native human papillomavirus type 16 virions. J. Virol. 2009, 83:10515-10526.
-
(2009)
J. Virol.
, vol.83
, pp. 10515-10526
-
-
Conway, M.J.1
Alam, S.2
Ryndock, E.J.3
Cruz, L.4
Christensen, N.D.5
Roden, R.B.6
Meyers, C.7
-
23
-
-
68749122026
-
4Cl and cysteine proteases in Human Papillomavirus type 16 infection
-
4Cl and cysteine proteases in Human Papillomavirus type 16 infection. Virol. J. 2009, 6:109.
-
(2009)
Virol. J.
, vol.6
, pp. 109
-
-
Dabydeen, S.A.1
Meneses, P.I.2
-
24
-
-
7644237129
-
The l2 minor capsid protein of human papillomavirus type 16 interacts with a network of nuclear import receptors
-
Darshan M.S., Lucchi J., Harding E., Moroianu J. The l2 minor capsid protein of human papillomavirus type 16 interacts with a network of nuclear import receptors. J. Virol. 2004, 78:12179-12188.
-
(2004)
J. Virol.
, vol.78
, pp. 12179-12188
-
-
Darshan, M.S.1
Lucchi, J.2
Harding, E.3
Moroianu, J.4
-
25
-
-
4644352291
-
Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression
-
Day P.M., Baker C.C., Lowy D.R., Schiller J.T. Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proc. Natl. Acad. Sci. USA 2004, 101:14252-14257.
-
(2004)
Proc. Natl. Acad. Sci. USA
, vol.101
, pp. 14252-14257
-
-
Day, P.M.1
Baker, C.C.2
Lowy, D.R.3
Schiller, J.T.4
-
26
-
-
42449153250
-
Mechanisms of human papillomavirus type 16 neutralization by l2 cross-neutralizing and l1 type-specific antibodies
-
Day P.M., Gambhira R., Roden R.B., Lowy D.R., Schiller J.T. Mechanisms of human papillomavirus type 16 neutralization by l2 cross-neutralizing and l1 type-specific antibodies. J. Virol. 2008, 82:4638-4646.
-
(2008)
J. Virol.
, vol.82
, pp. 4638-4646
-
-
Day, P.M.1
Gambhira, R.2
Roden, R.B.3
Lowy, D.R.4
Schiller, J.T.5
-
27
-
-
77956570980
-
In vivo mechanisms of vaccine-induced protection against HPV infection
-
Day P.M., Kines R.C., Thompson C.D., Jagu S., Roden R.B., Lowy D.R., Schiller J.T. In vivo mechanisms of vaccine-induced protection against HPV infection. Cell Host Microbe 2010, 8:260-270.
-
(2010)
Cell Host Microbe
, vol.8
, pp. 260-270
-
-
Day, P.M.1
Kines, R.C.2
Thompson, C.D.3
Jagu, S.4
Roden, R.B.5
Lowy, D.R.6
Schiller, J.T.7
-
28
-
-
0031984638
-
The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains
-
Day P.M., Roden R.B., Lowy D.R., Schiller J.T. The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains. J. Virol. 1998, 72:142-150.
-
(1998)
J. Virol.
, vol.72
, pp. 142-150
-
-
Day, P.M.1
Roden, R.B.2
Lowy, D.R.3
Schiller, J.T.4
-
29
-
-
74749099125
-
The role of furin in papillomavirus infection
-
Day P.M., Schiller J.T. The role of furin in papillomavirus infection. Future Microbiol. 2009, 4:1255-1262.
-
(2009)
Future Microbiol.
, vol.4
, pp. 1255-1262
-
-
Day, P.M.1
Schiller, J.T.2
-
31
-
-
84861648384
-
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
-
de Martel C., Ferlay J., Franceschi S., Vignat J., Bray F., Forman D., Plummer M. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012, 13:607-615.
-
(2012)
Lancet Oncol.
, vol.13
, pp. 607-615
-
-
de Martel, C.1
Ferlay, J.2
Franceschi, S.3
Vignat, J.4
Bray, F.5
Forman, D.6
Plummer, M.7
-
32
-
-
2942567871
-
Classification of papillomaviruses
-
de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., zur Hausen H. Classification of papillomaviruses. Virology 2004, 324:17-27.
-
(2004)
Virology
, vol.324
, pp. 17-27
-
-
de Villiers, E.M.1
Fauquet, C.2
Broker, T.R.3
Bernard, H.U.4
zur Hausen, H.5
-
33
-
-
77955099933
-
Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial
-
Dillner J., Kjaer S.K., Wheeler C.M., Sigurdsson K., Iversen O.E., Hernandez-Avila M., Perez G., Brown D.R., Koutsky L.A., Tay E.H., Garcia P., Ault K.A., Garland S.M., Leodolter S., Olsson S.E., Tang G.W., Ferris D.G., Paavonen J., Lehtinen M., Steben M., Bosch F.X., Joura E.A., Majewski S., Munoz N., Myers E.R., Villa L.L., Taddeo F.J., Roberts C., Tadesse A., Bryan J.T., Maansson R., Lu S., Vuocolo S., Hesley T.M., Barr E., Haupt R. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. Br. Med. J. 2010, 341:c3493.
-
(2010)
Br. Med. J.
, vol.341
-
-
Dillner, J.1
Kjaer, S.K.2
Wheeler, C.M.3
Sigurdsson, K.4
Iversen, O.E.5
Hernandez-Avila, M.6
Perez, G.7
Brown, D.R.8
Koutsky, L.A.9
Tay, E.H.10
Garcia, P.11
Ault, K.A.12
Garland, S.M.13
Leodolter, S.14
Olsson, S.E.15
Tang, G.W.16
Ferris, D.G.17
Paavonen, J.18
Lehtinen, M.19
Steben, M.20
Bosch, F.X.21
Joura, E.A.22
Majewski, S.23
Munoz, N.24
Myers, E.R.25
Villa, L.L.26
Taddeo, F.J.27
Roberts, C.28
Tadesse, A.29
Bryan, J.T.30
Maansson, R.31
Lu, S.32
Vuocolo, S.33
Hesley, T.M.34
Barr, E.35
Haupt, R.36
more..
-
34
-
-
0023201247
-
Identification of proteins encoded by the L1 and L2 open reading frames of human papillomavirus 1a
-
Doorbar J., Gallimore P.H. Identification of proteins encoded by the L1 and L2 open reading frames of human papillomavirus 1a. J. Virol. 1987, 61:2793-2799.
-
(1987)
J. Virol.
, vol.61
, pp. 2793-2799
-
-
Doorbar, J.1
Gallimore, P.H.2
-
35
-
-
84875771195
-
The biology and life-cycle of human papillomaviruses
-
Doorbar J., Quint W., Banks L., Bravo I.G., Stoler M., Broker T.R., Stanley M.A. The biology and life-cycle of human papillomaviruses. Vaccine 2012, 30(Suppl. 5):F55-70.
-
(2012)
Vaccine
, vol.30
, Issue.SUPPL. 5
-
-
Doorbar, J.1
Quint, W.2
Banks, L.3
Bravo, I.G.4
Stoler, M.5
Broker, T.R.6
Stanley, M.A.7
-
36
-
-
0036776613
-
Protective immunity to rabbit oral and cutaneous papillomaviruses by immunization with short peptides of L2, the minor capsid protein
-
Embers M.E., Budgeon L.R., Pickel M., Christensen N.D. Protective immunity to rabbit oral and cutaneous papillomaviruses by immunization with short peptides of L2, the minor capsid protein. J. Virol. 2002, 76:9798-9805.
-
(2002)
J. Virol.
, vol.76
, pp. 9798-9805
-
-
Embers, M.E.1
Budgeon, L.R.2
Pickel, M.3
Christensen, N.D.4
-
37
-
-
77954230704
-
A major role for the minor capsid protein of human papillomavirus Type 16 in immune escape
-
Fahey L.M., Raff A.B., Da Silva D.M., Kast W.M. A major role for the minor capsid protein of human papillomavirus Type 16 in immune escape. J. Immunol. 2009, 183:6151-6156.
-
(2009)
J. Immunol.
, vol.183
, pp. 6151-6156
-
-
Fahey, L.M.1
Raff, A.B.2
Da Silva, D.M.3
Kast, W.M.4
-
38
-
-
0013667554
-
Human papillomavirus DNA: physical map
-
Favre M., Orth G., Croissant O., Yaniv M. Human papillomavirus DNA: physical map. Proc. Natl. Acad. Sci. USA 1975, 72:4810-4814.
-
(1975)
Proc. Natl. Acad. Sci. USA
, vol.72
, pp. 4810-4814
-
-
Favre, M.1
Orth, G.2
Croissant, O.3
Yaniv, M.4
-
39
-
-
10044234323
-
The positively charged termini of L2 minor capsid protein required for bovine papillomavirus infection function separately in nuclear import and DNA binding
-
Fay A., Yutzy W.H.t., Roden R.B., Moroianu J. The positively charged termini of L2 minor capsid protein required for bovine papillomavirus infection function separately in nuclear import and DNA binding. J. Virol. 2004, 78:13447-13454.
-
(2004)
J. Virol.
, vol.78
, pp. 13447-13454
-
-
Fay, A.1
Yutzy, W.2
Roden, R.B.3
Moroianu, J.4
-
40
-
-
0037384987
-
Interactions between papillomavirus L1 and L2 capsid proteins
-
Finnen R.L., Erickson K.D., Chen X.J.S., Garcea R.L. Interactions between papillomavirus L1 and L2 capsid proteins. J. Virol. 2003, 77:4818-4826.
-
(2003)
J. Virol.
, vol.77
, pp. 4818-4826
-
-
Finnen, R.L.1
Erickson, K.D.2
Chen, X.J.S.3
Garcea, R.L.4
-
41
-
-
33745251121
-
Identification of a dynein interacting domain in the papillomavirus minor capsid protein l2
-
Florin L., Becker K.A., Lambert C., Nowak T., Sapp C., Strand D., Streeck R.E., Sapp M. Identification of a dynein interacting domain in the papillomavirus minor capsid protein l2. J. Virol. 2006, 80:6691-6696.
-
(2006)
J. Virol.
, vol.80
, pp. 6691-6696
-
-
Florin, L.1
Becker, K.A.2
Lambert, C.3
Nowak, T.4
Sapp, C.5
Strand, D.6
Streeck, R.E.7
Sapp, M.8
-
42
-
-
2442667773
-
Nuclear translocation of papillomavirus minor capsid protein L2 requires Hsc70
-
Florin L., Becker K.A., Sapp C., Lambert C., Sirma H., Muller M., Streeck R.E., Sapp M. Nuclear translocation of papillomavirus minor capsid protein L2 requires Hsc70. J. Virol. 2004, 78:5546-5553.
-
(2004)
J. Virol.
, vol.78
, pp. 5546-5553
-
-
Florin, L.1
Becker, K.A.2
Sapp, C.3
Lambert, C.4
Sirma, H.5
Muller, M.6
Streeck, R.E.7
Sapp, M.8
-
43
-
-
0036776336
-
Assembly and translocation of papillomavirus capsid proteins
-
Florin L., Sapp C., Streeck R.E., Sapp M. Assembly and translocation of papillomavirus capsid proteins. J. Virol. 2002, 76:10009-10014.
-
(2002)
J. Virol.
, vol.76
, pp. 10009-10014
-
-
Florin, L.1
Sapp, C.2
Streeck, R.E.3
Sapp, M.4
-
44
-
-
0036061103
-
Reorganization of nuclear domain 10 induced by papillomavirus capsid protein l2
-
Florin L., Schafer F., Sotlar K., Streeck R.E., Sapp M. Reorganization of nuclear domain 10 induced by papillomavirus capsid protein l2. Virology 2002, 295:97-107.
-
(2002)
Virology
, vol.295
, pp. 97-107
-
-
Florin, L.1
Schafer, F.2
Sotlar, K.3
Streeck, R.E.4
Sapp, M.5
-
45
-
-
72449124661
-
Role of L2 cysteines in papillomavirus infection and neutralization
-
Gambhira R., Jagu S., Karanam B., Day P.M., Roden R. Role of L2 cysteines in papillomavirus infection and neutralization. Virol. J. 2009, 6.
-
(2009)
Virol. J.
, vol.6
-
-
Gambhira, R.1
Jagu, S.2
Karanam, B.3
Day, P.M.4
Roden, R.5
-
46
-
-
35448929981
-
Protection of rabbits against challenge with rabbit papillomaviruses by immunization with the N terminus of human papillomavirus type 16 minor capsid antigen L2
-
Gambhira R., Jagu S., Karanam B., Gravitt P.E., Culp T.D., Christensen N.D., Roden R.B. Protection of rabbits against challenge with rabbit papillomaviruses by immunization with the N terminus of human papillomavirus type 16 minor capsid antigen L2. J. Virol. 2007, 81:11585-11592.
-
(2007)
J. Virol.
, vol.81
, pp. 11585-11592
-
-
Gambhira, R.1
Jagu, S.2
Karanam, B.3
Gravitt, P.E.4
Culp, T.D.5
Christensen, N.D.6
Roden, R.B.7
-
47
-
-
37049002453
-
A protective and broadly cross-neutralizing epitope of human papillomavirus L2
-
Gambhira R., Karanam B., Jagu S., Roberts J.N., Buck C.B., Bossis I., Alphs H., Culp T., Christensen N.D., Roden R.B. A protective and broadly cross-neutralizing epitope of human papillomavirus L2. J. Virol. 2007, 81:13927-13931.
-
(2007)
J. Virol.
, vol.81
, pp. 13927-13931
-
-
Gambhira, R.1
Karanam, B.2
Jagu, S.3
Roberts, J.N.4
Buck, C.B.5
Bossis, I.6
Alphs, H.7
Culp, T.8
Christensen, N.D.9
Roden, R.B.10
-
48
-
-
0036929734
-
Interaction of human papillomavirus type 16 L2 with cellular proteins: identification of novel nuclear body-associated proteins
-
Gornemann J., Hofmann T.G., Will H., Muller M. Interaction of human papillomavirus type 16 L2 with cellular proteins: identification of novel nuclear body-associated proteins. Virology 2002, 303:69-78.
-
(2002)
Virology
, vol.303
, pp. 69-78
-
-
Gornemann, J.1
Hofmann, T.G.2
Will, H.3
Muller, M.4
-
49
-
-
0028300962
-
Three-dimensional structure of vaccinia virus-produced human papillomavirus type 1 capsids
-
Hagensee M.E., Olson N.H., Baker T.S., Galloway D.A. Three-dimensional structure of vaccinia virus-produced human papillomavirus type 1 capsids. J. Virol. 1994, 68:4503-4505.
-
(1994)
J. Virol.
, vol.68
, pp. 4503-4505
-
-
Hagensee, M.E.1
Olson, N.H.2
Baker, T.S.3
Galloway, D.A.4
-
50
-
-
0029050335
-
Human papillomavirus type 16 capsids expose multiple type-restricted and type-common antigenic epitopes
-
Heino P., Skyldberg B., Lehtinen M., Rantala I., Hagmar B., Kreider J.W., Kirnbauer R., Dillner J. Human papillomavirus type 16 capsids expose multiple type-restricted and type-common antigenic epitopes. J. Gen. Virol. 1995, 76(Pt 5):1141-1153.
-
(1995)
J. Gen. Virol.
, vol.76
, Issue.PART 5
, pp. 1141-1153
-
-
Heino, P.1
Skyldberg, B.2
Lehtinen, M.3
Rantala, I.4
Hagmar, B.5
Kreider, J.W.6
Kirnbauer, R.7
Dillner, J.8
-
51
-
-
0034715583
-
Interaction of the papillomavirus transcription/replication factor, E2, and the viral capsid protein, L2
-
Heino P., Zhou J., Lambert P.F. Interaction of the papillomavirus transcription/replication factor, E2, and the viral capsid protein, L2. Virology 2000, 276:304-314.
-
(2000)
Virology
, vol.276
, pp. 304-314
-
-
Heino, P.1
Zhou, J.2
Lambert, P.F.3
-
52
-
-
15244344245
-
The minor capsid protein L2 contributes to two steps in the human papillomavirus type 31 life cycle
-
Holmgren S.C., Patterson N.A., Ozbun M.A., Lambert P.F. The minor capsid protein L2 contributes to two steps in the human papillomavirus type 31 life cycle. J. Virol. 2005, 79:3938-3948.
-
(2005)
J. Virol.
, vol.79
, pp. 3938-3948
-
-
Holmgren, S.C.1
Patterson, N.A.2
Ozbun, M.A.3
Lambert, P.F.4
-
53
-
-
77349123739
-
Mechanisms of cell entry by human papillomaviruses: an overview
-
Horvath C.A., Boulet G.A., Renoux V.M., Delvenne P.O., Bogers J.P. Mechanisms of cell entry by human papillomaviruses: an overview. Virol. J. 2010, 7:11.
-
(2010)
Virol. J.
, vol.7
, pp. 11
-
-
Horvath, C.A.1
Boulet, G.A.2
Renoux, V.M.3
Delvenne, P.O.4
Bogers, J.P.5
-
54
-
-
84755161558
-
Inhibition of nuclear entry of HPV16 pseudovirus-packaged DNA by an anti-HPV16 L2 neutralizing antibody
-
Ishii Y., Tanaka K., Kondo K., Takeuchi T., Mori S., Kanda T. Inhibition of nuclear entry of HPV16 pseudovirus-packaged DNA by an anti-HPV16 L2 neutralizing antibody. Virology 2010, 406:181-188.
-
(2010)
Virology
, vol.406
, pp. 181-188
-
-
Ishii, Y.1
Tanaka, K.2
Kondo, K.3
Takeuchi, T.4
Mori, S.5
Kanda, T.6
-
55
-
-
67449084618
-
Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines
-
Jagu S., Karanam B., Gambhira R., Chivukula S.V., Chaganti R.J., Lowy D.R., Schiller J.T., Roden R.B.S. Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines. J. Natl. Cancer Inst. 2009, 101:782-792.
-
(2009)
J. Natl. Cancer Inst.
, vol.101
, pp. 782-792
-
-
Jagu, S.1
Karanam, B.2
Gambhira, R.3
Chivukula, S.V.4
Chaganti, R.J.5
Lowy, D.R.6
Schiller, J.T.7
Roden, R.B.S.8
-
56
-
-
84873165077
-
Optimization of multimeric human papillomavirus l2 vaccines
-
Jagu S., Kwak K., Karanam B., Huh W.K., Damotharan V., Chivukula S.V., Roden R.B. Optimization of multimeric human papillomavirus l2 vaccines. PloS One 2013, 8:e55538.
-
(2013)
PloS One
, vol.8
-
-
Jagu, S.1
Kwak, K.2
Karanam, B.3
Huh, W.K.4
Damotharan, V.5
Chivukula, S.V.6
Roden, R.B.7
-
57
-
-
0024546844
-
Identification of L2 open reading frame gene products of bovine papillomavirus type 1 using monoclonal antibodies
-
Jin X.W., Cowsert L.M., Pilacinski W.P., Jenson A.B. Identification of L2 open reading frame gene products of bovine papillomavirus type 1 using monoclonal antibodies. J. Gen. Virol. 1989, 70(Pt 5):1133-1140.
-
(1989)
J. Gen. Virol.
, vol.70
, Issue.PART 5
, pp. 1133-1140
-
-
Jin, X.W.1
Cowsert, L.M.2
Pilacinski, W.P.3
Jenson, A.B.4
-
58
-
-
60049100934
-
Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus
-
Johnson K.M., Kines R.C., Roberts J.N., Lowy D.R., Schiller J.T., Day P.M. Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus. J. Virol. 2009, 83:2067-2074.
-
(2009)
J. Virol.
, vol.83
, pp. 2067-2074
-
-
Johnson, K.M.1
Kines, R.C.2
Roberts, J.N.3
Lowy, D.R.4
Schiller, J.T.5
Day, P.M.6
-
59
-
-
30344481121
-
A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes
-
Kamper N., Day P.M., Nowak T., Selinka H.C., Florin L., Bolscher J., Hilbig L., Schiller J.T., Sapp M. A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes. J. Virol. 2006, 80:759-768.
-
(2006)
J. Virol.
, vol.80
, pp. 759-768
-
-
Kamper, N.1
Day, P.M.2
Nowak, T.3
Selinka, H.C.4
Florin, L.5
Bolscher, J.6
Hilbig, L.7
Schiller, J.T.8
Sapp, M.9
-
60
-
-
67249108700
-
Developing vaccines against minor capsid antigen L2 to prevent papillomavirus infection
-
Karanam B., Jagu S., Huh W.K., Roden R.B. Developing vaccines against minor capsid antigen L2 to prevent papillomavirus infection. Immunol. Cell Biol. 2009, 87:287-299.
-
(2009)
Immunol. Cell Biol.
, vol.87
, pp. 287-299
-
-
Karanam, B.1
Jagu, S.2
Huh, W.K.3
Roden, R.B.4
-
61
-
-
77957193739
-
Papillomavirus infection requires gamma secretase
-
Karanam B., Peng S., Li T., Buck C., Day P.M., Roden R.B. Papillomavirus infection requires gamma secretase. J. Virol. 2010, 84:10661-10670.
-
(2010)
J. Virol.
, vol.84
, pp. 10661-10670
-
-
Karanam, B.1
Peng, S.2
Li, T.3
Buck, C.4
Day, P.M.5
Roden, R.B.6
-
62
-
-
77951499187
-
Vaccine against human papillomavirus: PATRICIA Study (PApilloma TRIal against Cancer In young Adults)
-
Kaufmann A.M., Nitschmann S. Vaccine against human papillomavirus: PATRICIA Study (PApilloma TRIal against Cancer In young Adults). Der Internist 2010, 51(410):412-413.
-
(2010)
Der Internist
, vol.51
, Issue.410
, pp. 412-413
-
-
Kaufmann, A.M.1
Nitschmann, S.2
-
63
-
-
0035825073
-
Nasal immunization of mice with peptide having a cross-neutralization epitope on minor capsid protein L2 of human papillomavirus type 16 elicit systemic and mucosal antibodies
-
Kawana K., Kawana Y., Yoshikawa H., Taketani Y., Yoshiike K., Kanda T. Nasal immunization of mice with peptide having a cross-neutralization epitope on minor capsid protein L2 of human papillomavirus type 16 elicit systemic and mucosal antibodies. Vaccine 2001, 19:1496-1502.
-
(2001)
Vaccine
, vol.19
, pp. 1496-1502
-
-
Kawana, K.1
Kawana, Y.2
Yoshikawa, H.3
Taketani, Y.4
Yoshiike, K.5
Kanda, T.6
-
64
-
-
0032486389
-
A surface immunodeterminant of human papillomavirus type 16 minor capsid protein L2
-
Kawana K., Matsumoto K., Yoshikawa H., Taketani Y., Kawana T., Yoshiike K., Kanda T. A surface immunodeterminant of human papillomavirus type 16 minor capsid protein L2. Virology 1998, 245:353-359.
-
(1998)
Virology
, vol.245
, pp. 353-359
-
-
Kawana, K.1
Matsumoto, K.2
Yoshikawa, H.3
Taketani, Y.4
Kawana, T.5
Yoshiike, K.6
Kanda, T.7
-
65
-
-
0032989277
-
Common neutralization epitope in minor capsid protein L2 of human papillomavirus types 16 and 6
-
Kawana K., Yoshikawa H., Taketani Y., Yoshiike K., Kanda T. Common neutralization epitope in minor capsid protein L2 of human papillomavirus types 16 and 6. J. Virol. 1999, 73:6188-6190.
-
(1999)
J. Virol.
, vol.73
, pp. 6188-6190
-
-
Kawana, K.1
Yoshikawa, H.2
Taketani, Y.3
Yoshiike, K.4
Kanda, T.5
-
66
-
-
0035130055
-
Human papillomavirus type 16 minor capsid protein l2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm
-
Kawana Y., Kawana K., Yoshikawa H., Taketani Y., Yoshiike K., Kanda T. Human papillomavirus type 16 minor capsid protein l2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm. J. Virol. 2001, 75:2331-2336.
-
(2001)
J. Virol.
, vol.75
, pp. 2331-2336
-
-
Kawana, Y.1
Kawana, K.2
Yoshikawa, H.3
Taketani, Y.4
Yoshiike, K.5
Kanda, T.6
-
67
-
-
30944470245
-
Factors influencing subcellular localization of the human papillomavirus L2 minor structural protein
-
Kieback E., Muller M. Factors influencing subcellular localization of the human papillomavirus L2 minor structural protein. Virology 2006, 345:199-208.
-
(2006)
Virology
, vol.345
, pp. 199-208
-
-
Kieback, E.1
Muller, M.2
-
68
-
-
73949127173
-
The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding
-
Kines R.C., Thompson C.D., Lowy D.R., Schiller J.T., Day P.M. The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding. Proc. Natl. Acad. Sci. USA 2009, 106:20458-20463.
-
(2009)
Proc. Natl. Acad. Sci. USA
, vol.106
, pp. 20458-20463
-
-
Kines, R.C.1
Thompson, C.D.2
Lowy, D.R.3
Schiller, J.T.4
Day, P.M.5
-
69
-
-
0027050013
-
Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic
-
Kirnbauer R., Booy F., Cheng N., Lowy D.R., Schiller J.T. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc. Natl. Acad. Sci. USA 1992, 89:12180-12184.
-
(1992)
Proc. Natl. Acad. Sci. USA
, vol.89
, pp. 12180-12184
-
-
Kirnbauer, R.1
Booy, F.2
Cheng, N.3
Lowy, D.R.4
Schiller, J.T.5
-
70
-
-
0030001427
-
Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization
-
Kirnbauer R., Chandrachud L.M., ONeil B.W., Wagner E.R., Grindlay G.J., Armstrong A., McGarvie G.M., Schiller J.T., Lowy D.R., Campo M.S. Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization. Virology 1996, 219:37-44.
-
(1996)
Virology
, vol.219
, pp. 37-44
-
-
Kirnbauer, R.1
Chandrachud, L.M.2
ONeil, B.W.3
Wagner, E.R.4
Grindlay, G.J.5
Armstrong, A.6
McGarvie, G.M.7
Schiller, J.T.8
Lowy, D.R.9
Campo, M.S.10
-
71
-
-
33746776212
-
Nuclear import strategies of high-risk HPV18 L2 minor capsid protein
-
Klucevsek K., Daley J., Darshan M.S., Bordeaux J., Moroianu J. Nuclear import strategies of high-risk HPV18 L2 minor capsid protein. Virology 2006, 352:200-208.
-
(2006)
Virology
, vol.352
, pp. 200-208
-
-
Klucevsek, K.1
Daley, J.2
Darshan, M.S.3
Bordeaux, J.4
Moroianu, J.5
-
72
-
-
0023032821
-
The L2 open reading frame of human papillomavirus type 1a encodes a minor structural protein carrying type-specific antigens
-
Komly C.A., Breitburd F., Croissant O., Streeck R.E. The L2 open reading frame of human papillomavirus type 1a encodes a minor structural protein carrying type-specific antigens. J. Virol. 1986, 60:813-816.
-
(1986)
J. Virol.
, vol.60
, pp. 813-816
-
-
Komly, C.A.1
Breitburd, F.2
Croissant, O.3
Streeck, R.E.4
-
73
-
-
70449109171
-
Nuclear location of minor capsid protein L2 is required for expression of a reporter plasmid packaged in HPV51 pseudovirions
-
Kondo K., Ishii Y., Mori S., Shimabukuro S., Yoshikawa H., Kanda T. Nuclear location of minor capsid protein L2 is required for expression of a reporter plasmid packaged in HPV51 pseudovirions. Virology 2009, 394:259-265.
-
(2009)
Virology
, vol.394
, pp. 259-265
-
-
Kondo, K.1
Ishii, Y.2
Mori, S.3
Shimabukuro, S.4
Yoshikawa, H.5
Kanda, T.6
-
74
-
-
80052370129
-
Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial
-
Kreimer A.R., Gonzalez P., Katki H.A., Porras C., Schiffman M., Rodriguez A.C., Solomon D., Jimenez S., Schiller J.T., Lowy D.R., van Doorn L.J., Struijk L., Quint W., Chen S., Wacholder S., Hildesheim A., Herrero R. Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial. Lancet Oncol. 2011, 12:862-870.
-
(2011)
Lancet Oncol.
, vol.12
, pp. 862-870
-
-
Kreimer, A.R.1
Gonzalez, P.2
Katki, H.A.3
Porras, C.4
Schiffman, M.5
Rodriguez, A.C.6
Solomon, D.7
Jimenez, S.8
Schiller, J.T.9
Lowy, D.R.10
van Doorn, L.J.11
Struijk, L.12
Quint, W.13
Chen, S.14
Wacholder, S.15
Hildesheim, A.16
Herrero, R.17
-
75
-
-
67749120150
-
Human papillomavirus type 16 infection of human keratinocytes requires clathrin and caveolin-1 and is brefeldin a sensitive
-
Laniosz V., Dabydeen S.A., Havens M.A., Meneses P.I. Human papillomavirus type 16 infection of human keratinocytes requires clathrin and caveolin-1 and is brefeldin a sensitive. J. Virol. 2009, 83:8221-8232.
-
(2009)
J. Virol.
, vol.83
, pp. 8221-8232
-
-
Laniosz, V.1
Dabydeen, S.A.2
Havens, M.A.3
Meneses, P.I.4
-
76
-
-
45749150395
-
Bovine papillomavirus type 1: from clathrin to caveolin
-
Laniosz V., Holthusen K.A., Meneses P.I. Bovine papillomavirus type 1: from clathrin to caveolin. J. Virol. 2008, 82:6288-6298.
-
(2008)
J. Virol.
, vol.82
, pp. 6288-6298
-
-
Laniosz, V.1
Holthusen, K.A.2
Meneses, P.I.3
-
77
-
-
34447292801
-
Bovine papillomavirus type 1 infection is mediated by SNARE syntaxin 18
-
Laniosz V., Nguyen K.C., Meneses P.I. Bovine papillomavirus type 1 infection is mediated by SNARE syntaxin 18. J. Virol. 2007, 81:7435-7448.
-
(2007)
J. Virol.
, vol.81
, pp. 7435-7448
-
-
Laniosz, V.1
Nguyen, K.C.2
Meneses, P.I.3
-
78
-
-
34447292801
-
Bovine papillomavirus type 1 infection is mediated by SNARE syntaxin 18
-
Laniosz V., Nguyen K.C., Meneses P.I. Bovine papillomavirus type 1 infection is mediated by SNARE syntaxin 18. J. Virol. 2007, 81:7435-7448.
-
(2007)
J. Virol.
, vol.81
, pp. 7435-7448
-
-
Laniosz, V.1
Nguyen, K.C.2
Meneses, P.I.3
-
79
-
-
84855300842
-
Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
-
Lehtinen M., Paavonen J., Wheeler C.M., Jaisamrarn U., Garland S.M., Castellsague X., Skinner S.R., Apter D., Naud P., Salmeron J., Chow S.N., Kitchener H., Teixeira J.C., Hedrick J., Limson G., Szarewski A., Romanowski B., Aoki F.Y., Schwarz T.F., Poppe W.A., De Carvalho N.S., Germar M.J., Peters K., Mindel A., De Sutter P., Bosch F.X., David M.P., Descamps D., Struyf F., Dubin G. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol. 2012, 13:89-99.
-
(2012)
Lancet Oncol.
, vol.13
, pp. 89-99
-
-
Lehtinen, M.1
Paavonen, J.2
Wheeler, C.M.3
Jaisamrarn, U.4
Garland, S.M.5
Castellsague, X.6
Skinner, S.R.7
Apter, D.8
Naud, P.9
Salmeron, J.10
Chow, S.N.11
Kitchener, H.12
Teixeira, J.C.13
Hedrick, J.14
Limson, G.15
Szarewski, A.16
Romanowski, B.17
Aoki, F.Y.18
Schwarz, T.F.19
Poppe, W.A.20
De Carvalho, N.S.21
Germar, M.J.22
Peters, K.23
Mindel, A.24
De Sutter, P.25
Bosch, F.X.26
David, M.P.27
Descamps, D.28
Struyf, F.29
Dubin, G.30
more..
-
80
-
-
0035340806
-
Papillomavirus-like particles induce acute activation of dendritic cells
-
Lenz, P., Day, P.M., Pang, Y.Y., Frye, S.A., Jensen, P.N., Lowy, D.R., Schiller, J.T., 2001. Papillomavirus-like particles induce acute activation of dendritic cells. J Immunol 166, 5346-5355.
-
(2001)
J Immunol
, vol.166
, pp. 5346-5355
-
-
Lenz, P.1
Day, P.M.2
Pang, Y.Y.3
Frye, S.A.4
Jensen, P.N.5
Lowy, D.R.6
Schiller, J.T.7
-
81
-
-
0030983747
-
Expression of the human papillomavirus type 11 L1 capsid protein in Escherichia coli: characterization of protein domains involved in DNA binding and capsid assembly
-
Li M., Cripe T.P., Estes P.A., Lyon M.K., Rose R.C., Garcea R.L. Expression of the human papillomavirus type 11 L1 capsid protein in Escherichia coli: characterization of protein domains involved in DNA binding and capsid assembly. J. Virol. 1997, 71:2988-2995.
-
(1997)
J. Virol.
, vol.71
, pp. 2988-2995
-
-
Li, M.1
Cripe, T.P.2
Estes, P.A.3
Lyon, M.K.4
Rose, R.C.5
Garcea, R.L.6
-
82
-
-
0026559988
-
Effective vaccination against papilloma development by immunization with L1 or L2 structural protein of cottontail rabbit papillomavirus
-
Lin Y.L., Borenstein L.A., Selvakumar R., Ahmed R., Wettstein F.O. Effective vaccination against papilloma development by immunization with L1 or L2 structural protein of cottontail rabbit papillomavirus. Virology 1992, 187:612-619.
-
(1992)
Virology
, vol.187
, pp. 612-619
-
-
Lin, Y.L.1
Borenstein, L.A.2
Selvakumar, R.3
Ahmed, R.4
Wettstein, F.O.5
-
83
-
-
58249119452
-
Expression pattern and subcellular localization of human papillomavirus minor capsid protein L2
-
Lin Z., Yemelyanova A.V., Gambhira R., Jagu S., Meyers C., Kirnbauer R., Ronnett B.M., Gravitt P.E., Roden R.B.S. Expression pattern and subcellular localization of human papillomavirus minor capsid protein L2. Am. J. Pathol. 2009, 174:136-143.
-
(2009)
Am. J. Pathol.
, vol.174
, pp. 136-143
-
-
Lin, Z.1
Yemelyanova, A.V.2
Gambhira, R.3
Jagu, S.4
Meyers, C.5
Kirnbauer, R.6
Ronnett, B.M.7
Gravitt, P.E.8
Roden, R.B.S.9
-
84
-
-
0031579249
-
Sequence close to the N-terminus of L2 protein is displayed on the surface of bovine papillomavirus type 1 virions
-
Liu W.J., Gissmann L., Sun X.Y., Kanjanahaluethai A., Muller M., Doorbar J., Zhou J. Sequence close to the N-terminus of L2 protein is displayed on the surface of bovine papillomavirus type 1 virions. Virology 1997, 227:474-483.
-
(1997)
Virology
, vol.227
, pp. 474-483
-
-
Liu, W.J.1
Gissmann, L.2
Sun, X.Y.3
Kanjanahaluethai, A.4
Muller, M.5
Doorbar, J.6
Zhou, J.7
-
85
-
-
60849085702
-
Evolutionary and structural analyses of alpha-papillomavirus capsid proteins yields novel insights into L2 structure and interaction with L1
-
Lowe J., Panda D., Rose S., Jensen T., Hughes W.A., Tso F.Y., Angeletti P.C. Evolutionary and structural analyses of alpha-papillomavirus capsid proteins yields novel insights into L2 structure and interaction with L1. Virol. J. 2008, 5.
-
(2008)
Virol. J.
, vol.5
-
-
Lowe, J.1
Panda, D.2
Rose, S.3
Jensen, T.4
Hughes, W.A.5
Tso, F.Y.6
Angeletti, P.C.7
-
86
-
-
0023255386
-
DNA-binding activity of papillomavirus proteins
-
Mallon R.G., Wojciechowicz D., Defendi V. DNA-binding activity of papillomavirus proteins. J. Virol. 1987, 61:1655-1660.
-
(1987)
J. Virol.
, vol.61
, pp. 1655-1660
-
-
Mallon, R.G.1
Wojciechowicz, D.2
Defendi, V.3
-
87
-
-
84855205694
-
The high risk HPV16 L2 minor capsid protein has multiple transport signals that mediate its nucleocytoplasmic traffic
-
Mamoor S., Onder Z., Karanam B., Kwak K., Bordeaux J., Crosby L., Roden R.B., Moroianu J. The high risk HPV16 L2 minor capsid protein has multiple transport signals that mediate its nucleocytoplasmic traffic. Virology 2012, 422:413-424.
-
(2012)
Virology
, vol.422
, pp. 413-424
-
-
Mamoor, S.1
Onder, Z.2
Karanam, B.3
Kwak, K.4
Bordeaux, J.5
Crosby, L.6
Roden, R.B.7
Moroianu, J.8
-
88
-
-
77957959661
-
Modification of human papillomavirus minor capsid protein L2 by sumoylation
-
Marusic M.B., Mencin N., Licen M., Banks L., Grm H.S. Modification of human papillomavirus minor capsid protein L2 by sumoylation. J. Virol. 2010, 84:11585-11589.
-
(2010)
J. Virol.
, vol.84
, pp. 11585-11589
-
-
Marusic, M.B.1
Mencin, N.2
Licen, M.3
Banks, L.4
Grm, H.S.5
-
89
-
-
0030820343
-
Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA
-
Meyers C., Mayer T.J., Ozbun M.A. Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA. J. Virol. 1997, 71:7381-7386.
-
(1997)
J. Virol.
, vol.71
, pp. 7381-7386
-
-
Meyers, C.1
Mayer, T.J.2
Ozbun, M.A.3
-
90
-
-
84868146517
-
Monoclonal antibodies recognizing cross-neutralization epitopes in human papillomavirus 16 minor capsid protein L2
-
Nakao S., Mori S., Kondo K., Matsumoto K., Yoshikawa H., Kanda T. Monoclonal antibodies recognizing cross-neutralization epitopes in human papillomavirus 16 minor capsid protein L2. Virology 2012, 434:110-117.
-
(2012)
Virology
, vol.434
, pp. 110-117
-
-
Nakao, S.1
Mori, S.2
Kondo, K.3
Matsumoto, K.4
Yoshikawa, H.5
Kanda, T.6
-
91
-
-
12844276619
-
Human papillomavirus 16 L2 inhibits the transcriptional activation function, but not the DNA replication function, of HPV-16 E2
-
Okoye A., Cordano P., Taylor E.R., Morgan I.M., Everett R., Campo M.S. Human papillomavirus 16 L2 inhibits the transcriptional activation function, but not the DNA replication function, of HPV-16 E2. Virus Res. 2005, 108:1-14.
-
(2005)
Virus Res.
, vol.108
, pp. 1-14
-
-
Okoye, A.1
Cordano, P.2
Taylor, E.R.3
Morgan, I.M.4
Everett, R.5
Campo, M.S.6
-
92
-
-
0035050517
-
L1 interaction domains of papillomavirus l2 necessary for viral genome encapsidation
-
Okun M.M., Day P.M., Greenstone H.L., Booy F.P., Lowy D.R., Schiller J.T., Roden R.B. L1 interaction domains of papillomavirus l2 necessary for viral genome encapsidation. J. Virol. 2001, 75:4332-4342.
-
(2001)
J. Virol.
, vol.75
, pp. 4332-4342
-
-
Okun, M.M.1
Day, P.M.2
Greenstone, H.L.3
Booy, F.P.4
Lowy, D.R.5
Schiller, J.T.6
Roden, R.B.7
-
93
-
-
61449235414
-
Establishment of human papillomavirus infection requires cell cycle progression
-
Pyeon D., Pearce S.M., Lank S.M., Ahlquist P., Lambert P.F. Establishment of human papillomavirus infection requires cell cycle progression. PLoS Pathog. 2009, 5:e1000318.
-
(2009)
PLoS Pathog.
, vol.5
-
-
Pyeon, D.1
Pearce, S.M.2
Lank, S.M.3
Ahlquist, P.4
Lambert, P.F.5
-
94
-
-
31944439998
-
Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection
-
Richards R.M., Lowy D.R., Schiller J.T., Day P.M. Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection. Proc. Natl. Acad. Sci. USA 2006, 103:1522-1527.
-
(2006)
Proc. Natl. Acad. Sci. USA
, vol.103
, pp. 1522-1527
-
-
Richards, R.M.1
Lowy, D.R.2
Schiller, J.T.3
Day, P.M.4
-
95
-
-
0024382871
-
Identification and characterization of the BPV-2 L2 protein
-
Rippe R.A., Meinke W.J. Identification and characterization of the BPV-2 L2 protein. Virology 1989, 171:298-301.
-
(1989)
Virology
, vol.171
, pp. 298-301
-
-
Rippe, R.A.1
Meinke, W.J.2
-
96
-
-
34447122482
-
Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan
-
Roberts J.N., Buck C.B., Thompson C.D., Kines R., Bernardo M., Choyke P.L., Lowy D.R., Schiller J.T. Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat. Med. 2007, 13:857-861.
-
(2007)
Nat. Med.
, vol.13
, pp. 857-861
-
-
Roberts, J.N.1
Buck, C.B.2
Thompson, C.D.3
Kines, R.4
Bernardo, M.5
Choyke, P.L.6
Lowy, D.R.7
Schiller, J.T.8
-
97
-
-
79955770732
-
Effect of pap smear collection and carrageenan on cervicovaginal human papillomavirus-16 infection in a rhesus macaque model
-
Roberts J.N., Kines R.C., Katki H.A., Lowy D.R., Schiller J.T. Effect of pap smear collection and carrageenan on cervicovaginal human papillomavirus-16 infection in a rhesus macaque model. J. Natl. Cancer Inst. 2011, 103:737-743.
-
(2011)
J. Natl. Cancer Inst.
, vol.103
, pp. 737-743
-
-
Roberts, J.N.1
Kines, R.C.2
Katki, H.A.3
Lowy, D.R.4
Schiller, J.T.5
-
98
-
-
0034790812
-
Positively charged termini of the L2 minor capsid protein are necessary for papillomavirus infection
-
Roden R.B., Day P.M., Bronzo B.K., Yutzy W.H.t., Yang Y., Lowy D.R., Schiller J.T. Positively charged termini of the L2 minor capsid protein are necessary for papillomavirus infection. J. Virol. 2001, 75:10493-10497.
-
(2001)
J. Virol.
, vol.75
, pp. 10493-10497
-
-
Roden, R.B.1
Day, P.M.2
Bronzo, B.K.3
Yutzy, W.4
Yang, Y.5
Lowy, D.R.6
Schiller, J.T.7
-
99
-
-
0029841214
-
In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype
-
Roden R.B., Greenstone H.L., Kirnbauer R., Booy F.P., Jessie J., Lowy D.R., Schiller J.T. In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype. J. Virol. 1996, 70:5875-5883.
-
(1996)
J. Virol.
, vol.70
, pp. 5875-5883
-
-
Roden, R.B.1
Greenstone, H.L.2
Kirnbauer, R.3
Booy, F.P.4
Jessie, J.5
Lowy, D.R.6
Schiller, J.T.7
-
100
-
-
0034630951
-
Minor capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopes
-
Roden R.B.S., Yutzy W.H., Fallon R., Inglis S., Lowy D.R., Schiller J.T. Minor capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopes. Virology 2000, 270:254-257.
-
(2000)
Virology
, vol.270
, pp. 254-257
-
-
Roden, R.B.S.1
Yutzy, W.H.2
Fallon, R.3
Inglis, S.4
Lowy, D.R.5
Schiller, J.T.6
-
101
-
-
71649087760
-
Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years
-
Romanowski B., de Borba P.C., Naud P.S., Roteli-Martins C.M., De Carvalho N.S., Teixeira J.C., Aoki F., Ramjattan B., Shier R.M., Somani R., Barbier S., Blatter M.M., Chambers C., Ferris D., Gall S.A., Guerra F.A., Harper D.M., Hedrick J.A., Henry D.C., Korn A.P., Kroll R., Moscicki A.B., Rosenfeld W.D., Sullivan B.J., Thoming C.S., Tyring S.K., Wheeler C.M., Dubin G., Schuind A., Zahaf T., Greenacre M., Sgriobhadair A. Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years. Lancet 2009, 374:1975-1985.
-
(2009)
Lancet
, vol.374
, pp. 1975-1985
-
-
Romanowski, B.1
de Borba, P.C.2
Naud, P.S.3
Roteli-Martins, C.M.4
De Carvalho, N.S.5
Teixeira, J.C.6
Aoki, F.7
Ramjattan, B.8
Shier, R.M.9
Somani, R.10
Barbier, S.11
Blatter, M.M.12
Chambers, C.13
Ferris, D.14
Gall, S.A.15
Guerra, F.A.16
Harper, D.M.17
Hedrick, J.A.18
Henry, D.C.19
Korn, A.P.20
Kroll, R.21
Moscicki, A.B.22
Rosenfeld, W.D.23
Sullivan, B.J.24
Thoming, C.S.25
Tyring, S.K.26
Wheeler, C.M.27
Dubin, G.28
Schuind, A.29
Zahaf, T.30
Greenacre, M.31
Sgriobhadair, A.32
more..
-
102
-
-
0025012317
-
Expression of the full-length products of the human papillomavirus type 6b (HPV-6b) and HPV-11 L2 open reading frames by recombinant baculovirus, and antigenic comparisons with HPV-11 whole virus particles
-
Rose R.C., Bonnez W., Strike D.G., Reichman R.C. Expression of the full-length products of the human papillomavirus type 6b (HPV-6b) and HPV-11 L2 open reading frames by recombinant baculovirus, and antigenic comparisons with HPV-11 whole virus particles. J. Gen. Virol. 1990, 71(Pt 11):2725-2729.
-
(1990)
J. Gen. Virol.
, vol.71
, Issue.PART 11
, pp. 2725-2729
-
-
Rose, R.C.1
Bonnez, W.2
Strike, D.G.3
Reichman, R.C.4
-
103
-
-
78650260831
-
The N-terminal region of the human papillomavirus L2 protein contains overlapping binding sites for neutralizing, cross-neutralizing and non-neutralizing antibodies
-
Rubio I., Seitz H., Canali E., Sehr P., Bolchi A., Tommasino M., Ottonello S., Muller M. The N-terminal region of the human papillomavirus L2 protein contains overlapping binding sites for neutralizing, cross-neutralizing and non-neutralizing antibodies. Virology 2011, 409:348-359.
-
(2011)
Virology
, vol.409
, pp. 348-359
-
-
Rubio, I.1
Seitz, H.2
Canali, E.3
Sehr, P.4
Bolchi, A.5
Tommasino, M.6
Ottonello, S.7
Muller, M.8
-
104
-
-
71949096137
-
Viral entry mechanisms: human papillomavirus and a long journey from extracellular matrix to the nucleus
-
Sapp M., Bienkowska-Haba M. Viral entry mechanisms: human papillomavirus and a long journey from extracellular matrix to the nucleus. FEBS J. 2009, 276:7206-7216.
-
(2009)
FEBS J.
, vol.276
, pp. 7206-7216
-
-
Sapp, M.1
Bienkowska-Haba, M.2
-
105
-
-
0036061310
-
DNA binding of L1 is required for human papillomavirus morphogenesis in vivo
-
Schafer F., Florin L., Sapp M. DNA binding of L1 is required for human papillomavirus morphogenesis in vivo. Virology 2002, 295:172-181.
-
(2002)
Virology
, vol.295
, pp. 172-181
-
-
Schafer, F.1
Florin, L.2
Sapp, M.3
-
106
-
-
84867843672
-
Understanding and learning from the success of prophylactic human papillomavirus vaccines
-
Schiller J.T., Lowy D.R. Understanding and learning from the success of prophylactic human papillomavirus vaccines. Nat. Rev. Microbiol. 2012, 10:681-692.
-
(2012)
Nat. Rev. Microbiol.
, vol.10
, pp. 681-692
-
-
Schiller, J.T.1
Lowy, D.R.2
-
107
-
-
84879462574
-
The transcription factors TBX2 and TBX3 interact with HPV16 L2 and repress the long control region of human papillomaviruses
-
Schneider M.A., Scheffer K.D., Bund T., Boukhallouk F., Lambert C., Cotarelo C., Pflugfelder G.O., Florin L., Spoden G.A. The transcription factors TBX2 and TBX3 interact with HPV16 L2 and repress the long control region of human papillomaviruses. J. Virol. 2013.
-
(2013)
J. Virol.
-
-
Schneider, M.A.1
Scheffer, K.D.2
Bund, T.3
Boukhallouk, F.4
Lambert, C.5
Cotarelo, C.6
Pflugfelder, G.O.7
Florin, L.8
Spoden, G.A.9
-
108
-
-
78650282789
-
Identification of the dynein light chains required for human papillomavirus infection
-
Schneider M.A., Spoden G.A., Florin L., Lambert C. Identification of the dynein light chains required for human papillomavirus infection. Cell. Microbiol. 2011, 13:32-46.
-
(2011)
Cell. Microbiol.
, vol.13
, pp. 32-46
-
-
Schneider, M.A.1
Spoden, G.A.2
Florin, L.3
Lambert, C.4
-
109
-
-
84870255590
-
Natural variants in the major neutralizing epitope of human papillomavirus minor capsid protein L2
-
Seitz H., Schmitt M., Bohmer G., Kopp-Schneider A., Muller M. Natural variants in the major neutralizing epitope of human papillomavirus minor capsid protein L2. Int. J. Cancer. Journal international du cancer 2013, 132:E139-148.
-
(2013)
Int. J. Cancer. Journal international du cancer
, vol.132
-
-
Seitz, H.1
Schmitt, M.2
Bohmer, G.3
Kopp-Schneider, A.4
Muller, M.5
-
110
-
-
0345599173
-
Further evidence that papillomavirus capsids exist in two distinct conformations
-
Selinka H.C., Giroglou T., Nowak T., Christensen N.D., Sapp M. Further evidence that papillomavirus capsids exist in two distinct conformations. J. Virol. 2003, 77:12961-12967.
-
(2003)
J. Virol.
, vol.77
, pp. 12961-12967
-
-
Selinka, H.C.1
Giroglou, T.2
Nowak, T.3
Christensen, N.D.4
Sapp, M.5
-
111
-
-
0028802473
-
Sequences required for the nuclear targeting and accumulation of human papillomavirus type 6B L2 protein
-
Sun X.Y., Frazer I., Muller M., Gissmann L., Zhou J. Sequences required for the nuclear targeting and accumulation of human papillomavirus type 6B L2 protein. Virology 1995, 213:321-327.
-
(1995)
Virology
, vol.213
, pp. 321-327
-
-
Sun, X.Y.1
Frazer, I.2
Muller, M.3
Gissmann, L.4
Zhou, J.5
-
112
-
-
84860891623
-
Essential roles for soluble virion-associated heparan sulfonated proteoglycans and growth factors in human papillomavirus infections
-
Surviladze Z., Dziduszko A., Ozbun M.A. Essential roles for soluble virion-associated heparan sulfonated proteoglycans and growth factors in human papillomavirus infections. PLoS Pathog. 2012, 8:e1002519.
-
(2012)
PLoS Pathog.
, vol.8
-
-
Surviladze, Z.1
Dziduszko, A.2
Ozbun, M.A.3
-
113
-
-
0000557716
-
Human papillomavirus DNA replication compartments in a transient DNA replication system
-
Swindle C.S., Zou N.X., Van Tine B.A., Shaw G.M., Engler J.A., Chow L.T. Human papillomavirus DNA replication compartments in a transient DNA replication system. J. Virol. 1999, 73:1001-1009.
-
(1999)
J. Virol.
, vol.73
, pp. 1001-1009
-
-
Swindle, C.S.1
Zou, N.X.2
Van Tine, B.A.3
Shaw, G.M.4
Engler, J.A.5
Chow, L.T.6
-
114
-
-
0030931283
-
Novel structural features of bovine papillomavirus capsid revealed by a three-dimensional reconstruction to 9 A resolution
-
Trus B.L., Roden R.B., Greenstone H.L., Vrhel M., Schiller J.T., Booy F.P. Novel structural features of bovine papillomavirus capsid revealed by a three-dimensional reconstruction to 9 A resolution. Nat. Struct. Biol. 1997, 4:413-420.
-
(1997)
Nat. Struct. Biol.
, vol.4
, pp. 413-420
-
-
Trus, B.L.1
Roden, R.B.2
Greenstone, H.L.3
Vrhel, M.4
Schiller, J.T.5
Booy, F.P.6
-
115
-
-
0030947009
-
Generation and neutralization of pseudovirions of human papillomavirus type 33
-
Unckell F., Streeck R.E., Sapp M. Generation and neutralization of pseudovirions of human papillomavirus type 33. J. Virol. 1997, 71:2934-2939.
-
(1997)
J. Virol.
, vol.71
, pp. 2934-2939
-
-
Unckell, F.1
Streeck, R.E.2
Sapp, M.3
-
116
-
-
84874096730
-
Virus-like particles for the prevention of human papillomavirus-associated malignancies
-
Wang J.W., Roden R.B. Virus-like particles for the prevention of human papillomavirus-associated malignancies. Expert Rev. Vaccines 2013, 12:129-141.
-
(2013)
Expert Rev. Vaccines
, vol.12
, pp. 129-141
-
-
Wang, J.W.1
Roden, R.B.2
-
117
-
-
84865156591
-
The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection
-
Woodham A.W., Da Silva D.M., Skeate J.G., Raff A.B., Ambroso M.R., Brand H.E., Isas J.M., Langen R., Kast W.M. The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection. PloS One 2012, 7:e43519.
-
(2012)
PloS One
, vol.7
-
-
Woodham, A.W.1
Da Silva, D.M.2
Skeate, J.G.3
Raff, A.B.4
Ambroso, M.R.5
Brand, H.E.6
Isas, J.M.7
Langen, R.8
Kast, W.M.9
-
118
-
-
84884352943
-
-
Defining protective N-terminal epitopes of L2 using rat monoclonal antibodies, 27th International Papillomavirus conference and clinical workshop, Berlin, Germany
-
Wu, W.H., Kwak, K., Jagu, S., Huh, W.K., Roden, R.B., 2011. Defining protective N-terminal epitopes of L2 using rat monoclonal antibodies, 27th International Papillomavirus conference and clinical workshop, Berlin, Germany.
-
(2011)
-
-
Wu, W.H.1
Kwak, K.2
Jagu, S.3
Huh, W.K.4
Roden, R.B.5
-
119
-
-
2942702212
-
Despite differences between dendritic cells and Langerhans cells in the mechanism of papillomavirus-like particle antigen uptake, both cells cross-prime T cells
-
Yan M.Y., Peng J., Jabbar I.A., Liu X.S., Filgueira L., Frazer I.H., Thomas R. Despite differences between dendritic cells and Langerhans cells in the mechanism of papillomavirus-like particle antigen uptake, both cells cross-prime T cells. Virology 2004, 324:297-310.
-
(2004)
Virology
, vol.324
, pp. 297-310
-
-
Yan, M.Y.1
Peng, J.2
Jabbar, I.A.3
Liu, X.S.4
Filgueira, L.5
Frazer, I.H.6
Thomas, R.7
-
120
-
-
0037333367
-
Cell surface-binding motifs of L2 that facilitate papillomavirus infection
-
Yang R., Day P.M., Yutzy W.H.t., Lin K.Y., Hung C.F., Roden R.B. Cell surface-binding motifs of L2 that facilitate papillomavirus infection. J. Virol. 2003, 77:3531-3541.
-
(2003)
J. Virol.
, vol.77
, pp. 3531-3541
-
-
Yang, R.1
Day, P.M.2
Yutzy, W.3
Lin, K.Y.4
Hung, C.F.5
Roden, R.B.6
-
121
-
-
0038485582
-
Interaction of L2 with beta-actin directs intracellular transport of papillomavirus and infection
-
Yang R., Yutzy W.H.t., Viscidi R.P., Roden R.B. Interaction of L2 with beta-actin directs intracellular transport of papillomavirus and infection. J. Biol. Chem. 2003, 278:12546-12553.
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 12546-12553
-
-
Yang, R.1
Yutzy, W.2
Viscidi, R.P.3
Roden, R.B.4
-
122
-
-
0032502751
-
DNA packaging by L1 and L2 capsid proteins of bovine papillomavirus type 1
-
Zhao K.N., Sun X.Y., Frazer I.H., Zhou J. DNA packaging by L1 and L2 capsid proteins of bovine papillomavirus type 1. Virology 1998, 243:482-491.
-
(1998)
Virology
, vol.243
, pp. 482-491
-
-
Zhao, K.N.1
Sun, X.Y.2
Frazer, I.H.3
Zhou, J.4
-
123
-
-
0028120905
-
Interaction of human papillomavirus (HPV) type 16 capsid proteins with HPV DNA requires an intact L2 N-terminal sequence
-
Zhou J., Sun X.Y., Louis K., Frazer I.H. Interaction of human papillomavirus (HPV) type 16 capsid proteins with HPV DNA requires an intact L2 N-terminal sequence. J. Virol. 1994, 68:619-625.
-
(1994)
J. Virol.
, vol.68
, pp. 619-625
-
-
Zhou, J.1
Sun, X.Y.2
Louis, K.3
Frazer, I.H.4
-
124
-
-
0036559896
-
Papillomaviruses and cancer: from basic studies to clinical application
-
zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2002, 2:342-350.
-
(2002)
Nat. Rev. Cancer
, vol.2
, pp. 342-350
-
-
zur Hausen, H.1
|